Dr. Szalanczy joins DRA as a Medical Writer with prior experience related to oncology and early phase clinical trials. She is experienced in writing and updating clinical protocols and informed consent documents and Development Safety Update Reports (DSURs).
Prior to joining DRA, Dr. Szalanczy was a Medical Writer at Technical Resources International, Inc. She holds a Ph.D. in Molecular Medicine & Translational Science from Wake Forest University and a B.S. in Biochemistry & Molecular Biology from Centre College.